THOC5 Spliceosome Protein: a Target for Leukaemogenic Tyrosine Kinases That Affects Inositol Lipid Turnover
Overview
Authors
Affiliations
The fusion protein TEL/PDGFRB is associated with chronic myelomonocytic leukaemia and has intrinsic tyrosine kinase activity. The effects of TEL/PDGFRB were assessed using the multipotent haemopoietic cell line FDCP-Mix. In the absence of growth factors, TEL/PDGFRB expression increased survival that was associated with elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PIP3). Whilst TEL/PDGFRB had subtle effects on the growth factor requirements it had a profound effect on differentiation. The cells became refractory to cytokine-stimulated development, showing limited maturation but failing to produce fully mature cells. We have previously identified the spliceosome protein THOC5 as a target in macrophage colony-stimulating factor signalling and a protein involved in the regulation of transcription factor expression. TEL/PDGFRB expression increased the expression and phosphorylation of THOC5. Elevated expression of THOC5 increased PIP3 levels and decreased apoptosis. Mass spectrometry was used to identify a site for TEL/PDGFRB-mediated phosphorylation on THOC5, which was shown to be a target for a number of other leukaemogenic tyrosine kinases. Thus, THOC5 is a novel target for modulation of signal transduction with a potential role in leukaemogenesis.
Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patients.
Pearson S, Blance R, Yan F, Hsieh Y, Geary B, Amaral F PLoS One. 2023; 18(5):e0286412.
PMID: 37253035 PMC: 10228771. DOI: 10.1371/journal.pone.0286412.
THOC5 regulates human osteoclastogenesis.
Mun S, Oh B, Lee M, Bae S, Yang Y, Park-Min K Eur J Cell Biol. 2022; 101(3):151248.
PMID: 35688054 PMC: 11058851. DOI: 10.1016/j.ejcb.2022.151248.
Xie Y, Luo X, He H, Pan T, He Y Cancer Med. 2021; 10(8):2703-2713.
PMID: 33749163 PMC: 8026940. DOI: 10.1002/cam4.3859.
Whetton A, Azmi N, Pearson S, Jaworska E, Zhang L, Blance R Oncotarget. 2016; 7(10):10739-55.
PMID: 26919114 PMC: 4905435. DOI: 10.18632/oncotarget.7639.
Saran S, Tran D, Ewald F, Koch A, Hoffmann A, Koch M Oncogene. 2015; 35(29):3872-9.
PMID: 26549021 DOI: 10.1038/onc.2015.433.